The Public Accounts Committee sets out new measures intended to improve treatment for diabetes patients and bolster prevention of the condition. In its report, the Committee finds weaknesses in the approach of the DH and NHS England mean "the costs of diabetes to the NHS will continue to rise". There remain "unacceptable variations in the take up of education programmes, delivery of recommended care processes, achievement of treatment standards and in outcomes for diabetes patients". |